Commonwealth Equity Services LLC Trims Stake in Haleon plc (NYSE:HLN)

Commonwealth Equity Services LLC cut its stake in Haleon plc (NYSE:HLN) by 7.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 237,985 shares of the company’s stock after selling 18,745 shares during the period. Commonwealth Equity Services LLC’s holdings in Haleon were worth $1,966,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of HLN. Janney Montgomery Scott LLC grew its holdings in shares of Haleon by 182.3% during the first quarter. Janney Montgomery Scott LLC now owns 438,833 shares of the company’s stock valued at $3,726,000 after buying an additional 283,410 shares during the last quarter. Capstone Investment Advisors LLC bought a new position in shares of Haleon during the first quarter valued at approximately $1,969,000. Wellington Management Group LLP grew its holdings in shares of Haleon by 164.6% in the fourth quarter. Wellington Management Group LLP now owns 13,542,346 shares of the company’s stock worth $111,454,000 after purchasing an additional 8,423,475 shares during the last quarter. Douglas Lane & Associates LLC increased its holdings in Haleon by 2.1% during the first quarter. Douglas Lane & Associates LLC now owns 8,401,876 shares of the company’s stock valued at $71,332,000 after buying an additional 175,082 shares during the period. Finally, Procyon Advisors LLC boosted its position in Haleon by 559.9% during the 1st quarter. Procyon Advisors LLC now owns 131,665 shares of the company’s stock valued at $1,118,000 after acquiring an additional 111,713 shares in the last quarter. 6.67% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. Berenberg Bank initiated coverage on Haleon in a research note on Tuesday, August 6th. They set a “buy” rating on the stock. The Goldman Sachs Group cut Haleon from a “buy” rating to a “neutral” rating in a report on Tuesday, August 6th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy”.

Haleon Stock Performance

NYSE HLN opened at $10.50 on Friday. Haleon plc has a fifty-two week low of $7.70 and a fifty-two week high of $10.52. The firm has a market capitalization of $47.90 billion, a P/E ratio of 35.00, a price-to-earnings-growth ratio of 3.10 and a beta of 0.26. The stock’s fifty day moving average is $9.58 and its two-hundred day moving average is $8.79. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84.

Haleon (NYSE:HLN) last issued its earnings results on Thursday, August 1st. The company reported $0.08 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). Haleon had a return on equity of 13.15% and a net margin of 9.71%. The firm had revenue of $3.50 billion for the quarter, compared to analysts’ expectations of $3.55 billion. During the same period last year, the firm earned $0.08 earnings per share. On average, research analysts anticipate that Haleon plc will post 0.46 earnings per share for the current year.

Haleon Cuts Dividend

The firm also recently disclosed a semi-annual dividend, which will be paid on Thursday, September 19th. Investors of record on Friday, August 16th will be given a $0.0514 dividend. The ex-dividend date of this dividend is Friday, August 16th. This represents a yield of 1.6%. Haleon’s payout ratio is 33.33%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.